Results 331 to 340 of about 678,452 (368)
Some of the next articles are maybe not open access.
Hypoxia-inducible factor-1 (HIF-1)
Critical Care Medicine, 2005P. Schumacker
openaire +3 more sources
The role of hypoxia‐inducible factor 1 in tumor immune evasion
Medicinal research reviews (Print), 2020Hypoxia‐inducible factor 1 (HIF‐1) plays an indispensable role in the hypoxic tumor microenvironment. Hypoxia and HIF‐1 are involved in multiple aspects of tumor progression, such as metastasis, angiogenesis, and immune evasion.
L. You +7 more
semanticscholar +1 more source
Hypoxia Induces Transcription Factor ETS-1 via the Activity of Hypoxia-Inducible Factor-1
Biochemical and Biophysical Research Communications, 2001ETS-1 plays an important role in angiogenesis and cancer invasion, and hypoxia is a common feature in these phenomena. We examined whether hypoxia influenced ETS-1 expression. Hypoxia induced ETS-1 in a human bladder cancer cell line, T24, and promoter analysis revealed that the deletion of -424 to -279 bp from the human ETS-1 promoter decreased the ...
M, Oikawa +5 more
openaire +2 more sources
Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy
Antioxidants and Redox Signaling, 2020Significance: Hypoxia is emerging as a crucial regulator of the tumor microenvironment; it governs the metastatic potential of multiple primary cancers.
Zhaowu Ma +10 more
semanticscholar +1 more source
ACS Nano, 2018
Hypoxia, and hypoxia inducible factor-1 (HIF-1), can induce tumor resistance to radiation therapy. To overcome hypoxia-induced radiation resistance, recent studies have described nanosystems to improve tumor oxygenation for immobilizing DNA damage and ...
Lingtong Meng +11 more
semanticscholar +1 more source
Hypoxia, and hypoxia inducible factor-1 (HIF-1), can induce tumor resistance to radiation therapy. To overcome hypoxia-induced radiation resistance, recent studies have described nanosystems to improve tumor oxygenation for immobilizing DNA damage and ...
Lingtong Meng +11 more
semanticscholar +1 more source
Hypoxia-inducible factor 1 (HIF-1) in cancer
European Journal of Surgical Oncology (EJSO), 2004Hypoxia is a common feature of many cancers. It contributes to local and systemic tumour progression as well as potentially compromising radiotherapy and chemotherapy. Hypoxia-inducible factor 1 (HIF-1) is an essential component in changing the transcriptional response of tumours under hypoxia.
M, Quintero, N, Mackenzie, P A, Brennan
openaire +2 more sources
Hypoxia‐inducible factor‐1 and oncogenic signalling
BioEssays, 2004AbstractAn understanding of underlying mechanisms involved in the activation of HIF‐1 in response to both hypoxic stress and oncogenic signals has important implications for how these processes may become deregulated in human cancer. Changes in microenvironmental stimuli such as hypoxia and growth factors in combination with genetic lesions, such as ...
Bardos, JI, Athcroft, M
openaire +3 more sources
Dexamethasone impairs hypoxia-inducible factor-1 function
Biochemical and Biophysical Research Communications, 2008Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription-factor composed of alpha- and beta-subunits. HIF-1 is not only necessary for the cellular adaptation to hypoxia, but it is also involved in inflammatory processes and wound healing. Glucocorticoids (GC) are therapeutically used to suppress inflammatory responses.
A E, Wagner +4 more
openaire +2 more sources
Hypoxia-inducible factor 1 in autoimmune diseases
Cellular Immunology, 2016Autoimmune disorders are a complicated and varied group of diseases arising from inappropriate immune responses. Recent studies have demonstrated that ongoing inflammatory and immune responses are associated with increased oxygen consumption, a process resulting in localized tissue hypoxia within inflammatory lesions ("inflammatory hypoxia"), in which ...
Wei, Deng +4 more
openaire +2 more sources
Hypoxia‐Inducible Factor 1 Inhibitors
2007The tremendous progress in our understanding of the molecular mechanisms underlying the presence and consequences of hypoxia in human cancers has been accompanied by renewed enthusiasm for the development of therapeutic strategies targeting hypoxic cells signaling pathways.
openaire +2 more sources

